EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Johanna J.M. Takkenberg
Jos A. Bekkers
Ad J.J.C. Bogers
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takkenberg, J. J.M.
Right arrow Articles by Bogers, A. J.J.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takkenberg, J. J.M.
Right arrow Articles by Bogers, A. J.J.C.
Related Collections
Right arrow Valve disease

Eur J Cardiothorac Surg 2007;31:851-859. doi:10.1016/j.ejcts.2007.02.009
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study

Johanna J.M. Takkenberg*, Loes M.A. Klieverik, Jos A. Bekkers, Arie Pieter Kappetein, Jolien W. Roos, Marinus J.C. Eijkemans, Ad J.J.C. Bogers

Departments of Cardio-Thoracic Surgery, Cardiology, and Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands

Received 9 September 2006; received in revised form 5 January 2007; accepted 8 February 2007.

* Corresponding author. Address: Department of Cardio-Thoracic Surgery, Bd563, ErasmusMC, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Tel.: +31 10 4635413; fax: +31 10 4633993. (Email: j.j.m.takkenberg{at}erasmusmc.nl).

Objective: Whether allografts are the biological valve of choice for AVR in non-elderly patients remains a topic of debate. In this light we analyzed our ongoing prospective allograft AVR cohort and compared allograft durability with other biological aortic valve substitutes. Methods: Between April 1987 and October 2005, 336 patients underwent 346 allograft AVRs (95 subcoronary, 251 root replacement). Patient and perioperative characteristics, cumulative survival, freedom from reoperation, and valve-related events were analyzed. Using microsimulation, for adult patients, age-matched actual freedom from allograft reoperation was compared to porcine and pericardial bioprostheses. Results: Mean age was 45 years (range 1 month to 83 years); 72% were males. Etiology was mainly endocarditis 32% (active 22%), congenital 31%, degenerative 9%, and aneurysm/dissection 12%. Twenty-seven percent underwent prior cardiac surgery. Hospital mortality was 5.5% (N = 19). During follow-up (mean 7.4 years, maximum 18.5 years, 98% complete), 54 patients died; there were 57 valve-related reoperations (3 early technical, 11 non-structural, 39 structural valve deterioration (SVD), 4 endocarditis), 5 cerebrovascular accidents, 1 fatal bleeding, 8 endocarditis. Twelve-year cumulative survival was 71% (SE 3), freedom from reoperation for SVD 77% (SE 4); younger patient age was associated with increased SVD rates. Actual risk of allograft reoperation was comparable to porcine and pericardial bioprostheses in a simulated age-matched population. Conclusions: The use of allografts for AVR is associated with low occurrence rates of most valve-related events, but over time the risk of SVD increases, comparable to stented xenografts. It remains in our institute the preferred valve substitute only for patients with active aortic root endocarditis and for patients in whom anticoagulation should be avoided.

Key Words: Aortic valve replacement • Allografts • Prognosis • Reoperation




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. S. Borer and L. N. Girardi
Repair of the congenitally bicuspid regurgitant aortic valve a strategic advance.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 50 - 51.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Masuda, H. Kado, Y. Ando, A. Shiose, T. Nakano, K. Fukae, Y. Tanoue, and R. Tominaga
Intermediate-term results after the aortic valve replacement using bileaflet mechanical prosthetic valve in children.
Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 42 - 47.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.